MT HB 628 Fiscal Note (2019 Biennium)

Description of fiscal impact: HB 628 establishes a new reporting requirement of pricing factors for certain prescription drugs. Manufacturer’s whose wholesale acquisition cost increases by more than triple the increase in the consumer price index for medical care commodities, shall provide all relevant information to the State Auditor’s Office as well as supporting documentation to justify the cost increase.